Addex Therapeutics Ltd (ADXN) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Addex Therapeutics Ltd

NASDAQ: ADXN · Real-Time Price · USD
9.20
-0.19 (-2.02%)
At close: Oct 03, 2025, 3:16 PM
9.07
-1.41%
After-hours: Oct 03, 2025, 04:00 PM EDT

Addex Therapeutics Ltd Income Statement

Financials in CHF. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
410.04K 1.61M 1.42M 2.92M
Cost of Revenue
854.3K 6.94M 14.62M 12.82M
Gross Profit
-444.26K 430.5K -13.2M -9.67M
Operating Income
-2.76M -10.28M -10.54M -15.51M
Interest Income
9.16K 63.96K 29.25K 5.32K
Pretax Income
-4.91M -10.56M -10.8M -15.35M
Net Income
7.06M -10.56M -20.8M -15.35M
Selling & General & Admin
1.68M 4.99M 7.3M 5.14M
Research & Development
854.3K 6.96M 14.67M 12.84M
Other Expenses
-218.51K -9.28M -18.21M -12.14M
Operating Expenses
2.31M 2.67M 3.76M 5.84M
Interest Expense
3.55K 21.61K 48.9K 63.01K
Selling & Marketing Expenses
n/a -2.21M n/a n/a
Cost & Expenses
3.16M 11.89M 11.96M 18.66M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
817.61K 619.23K 376.54K 284.33K
Shares Outstanding (Diluted)
817.61K 619.23K 376.54K 284.33K
EPS (Basic)
8.40 -16.8 -55.2 -54
EPS (Diluted)
8.40 -16.8 -55.2 -54
EBITDA
-4.65M -10.23M -10.53M -14.94M
EBIT
-4.91M -10.53M -10.78M -15.29M
Depreciation & Amortization
260.12K 305.95K 8.81K 347.61K